Psychedelic medicine: safety and ethical concerns

Summary & key facts

This paper warns that new medical uses of psychedelics—like psilocybin and MDMA—could help with hard-to-treat depression, trauma, and addiction, but they also create special safety and ethical problems. Early studies show these drugs are often tolerated, but they can leave people more suggestible, emotionally unstable, or changed in how they see themselves and others. The authors say the main risks come from how therapists and patients interact, from hype and grandiosity, and from a lack of formal training and oversight. They call for clear rules, strong training, peer review, and guarded clinical practice before these treatments are widely offered.

Key facts:

• The authors note that regulators have given fast-track attention to MDMA and psilocybin, which has raised strong interest from researchers and investors.
• Early clinical trials suggest classic and atypical psychedelics are often tolerated, but that does not mean they are risk-free.
• Psychedelics can produce lasting changes like increased suggestibility, unstable emotions, and shifts in a person’s sense of self and social behaviour.
• Because of those lasting effects, people can be in a vulnerable state during and after treatment sessions, not just while the drug is active.
• The paper warns that problems are likely to come more from therapist–patient dynamics than from the drugs’ raw effectiveness; for example, informed consent, conflicts of interest, and working beyond a clinician’s skills are big concerns.
• The authors describe risks of grandiosity among people who take psychedelics and risks that patients may overly admire or become dependent on their therapists.
• The authors draw on their own work in early clinical trials and community studies, and on many calls from people harmed by difficult psychedelic experiences or unethical providers.
• To reduce harm, the authors call for higher standards: formal training for psychedelic therapists, routine peer review and supervision, clear quality checks, and guidance from established medical specialties that care for vulnerable patients.

Topics

Chemical synthesis and alkaloids Complementary and Alternative Medicine Studies Psychedelics and Drug Studies

Categories

Clinical Psychology Psychology Social Sciences

Tags

Alternative medicine Art Art history Engineering Engineering ethics Enthusiasm Epistemology Medicine Pathology Philosophy Pragmatism Psychology Social psychology The Renaissance

Substances

LSD MDMA Psilocybin

Conditions & symptoms

Addiction Depression PTSD Anxiety or worry Feeling disconnected from others Sadness or low mood